News & Views
Schott and Xinkang Agree on Joint Venture in China
Jan 16 2012
German technology group Schott and the Chinese company Zhejiang Xinkang Pharmaceutical Glass Co, Ltd have signed an agreement to establish a pharmaceutical packaging joint venture in China. Schott will own the majority of shares of the new company that will supply the fast-growing Chinese pharmaceutical market with high-quality
pharmaceutical packaging products made of glass. The closing of the joint venture is subject to customary closing conditions.
“With the formation of this joint venture between Schott and Xinkang, two strong partners are joining forces. By combining Xinkang’s knowledge of the local market with Schott’s technological expertise, we will be able to supply Chinese pharmaceutical companies with high-quality packaging products even more effectively in the future,” explained Professor Udo Ungeheuer, Chairman of the Board of Management of Schott AG. With this joint venture, Schott will be strengthening its position in the important growth market of China and continuing its expansion in the emerging pharmaceutical markets.
Schott Pharmaceutical Systems already operates manufacturing facilities in Brazil, Russia and India. The joint enterprise will manufacture at both Schott’s existing site in Suzhou, Jiangsu Province and in Jinyun, Zhejiang Province.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria